Manufacturing

How Has LGM Pharma Transformed Under Raje's Vision?
Management & Regulatory How Has LGM Pharma Transformed Under Raje's Vision?

Under the insightful leadership of executives like Raje, LGM Pharma has experienced significant evolution since being acquired by New Harbour Capital Private Equity. Initially, LGM Pharma was primarily focused on supply chain logistics within the pharmaceutical industry. However, it has since

How Will Upstream Bioprocessing Transform Biopharma?
Biotech & Bioprocessing How Will Upstream Bioprocessing Transform Biopharma?

Upstream bioprocessing is pivotal in biomanufacturing, where cellular systems produce vital therapeutic proteins and biological products. This field is experiencing a surge of innovative methods in response to the increased global demand for biopharmaceuticals driven by rising health concerns.

Is Lantern Pharma's LP-300 a New Hope for NSCLC Patients?
Management & Regulatory Is Lantern Pharma's LP-300 a New Hope for NSCLC Patients?

Lantern Pharma's LP-300 signals a significant advancement in the fight against non-small cell lung cancer (NSCLC), particularly in never-smokers—a group seeing elevated incidence rates, notably in East Asia. This promising therapeutic option stands out as NSCLC treatments often overlook the unique

How Is Tech Innovation Shaping Biopharma Production?
Biotech & Bioprocessing How Is Tech Innovation Shaping Biopharma Production?

How Is Tech Innovation Shaping Biopharma Production? The biopharmaceutical industry is experiencing profound change thanks to technological advancements. These innovations are not just fine-tuning existing methods; they're revolutionizing drug development and production. Advanced analytics and

Single-Use Tech in Biopharma: Cost, Eco-Friendly, and Flexible
Management & Regulatory Single-Use Tech in Biopharma: Cost, Eco-Friendly, and Flexible

In a decisive response to safeguard the stability of the financial system, the United States government has stepped forward with a bold assurance directed at customers of the recently collapsed Silicon Valley Bank (SVB). Officials have made a clear commitment that starting Monday, those affected

NIIMBL Invests $10M in Biopharma Manufacturing Innovation
Management & Regulatory NIIMBL Invests $10M in Biopharma Manufacturing Innovation

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently announced an ambitious new program, Project Call 7.1, to stimulate advancement in biopharmaceutical production and broaden workforce capabilities. With a funding pool of around $10 million, NIIMBL plans

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later